Navigation Links
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
Date:5/20/2013

f the transactions announced today
  • Despite this apparent lack of information, the Elan Board has agreed to recommend the Theravance Transaction to Elan Stockholders with no "fiduciary out" to change its recommendation:
    • The Elan Board has compromised its ability to freely advise Elan Stockholders regarding Royalty Pharma's offer and the Theravance Transaction, thereby making itself irrelevant to stockholders' decisions on these matters
    • The Elan Board cannot recommend Royalty Pharma's offer – at any price – without breaching the Theravance Agreement
    • The Elan Board must recommend the Theravance Transaction even if the value of what it has agreed to buy is impacted by material adverse changes
  • Royalty Pharma believes it is highly irresponsible and "off-market" to agree to such provisions
  • If the Theravance Transaction and the transactions announced today serve as examples, Royalty Pharma believes stockholders should be very concerned about future value destruction and undue risk-taking by Elan
  • At a time when Elan Stockholders are evaluating Royalty Pharma's offer, the Elan directors have failed to maintain an appropriate balance between supporting management's acquisition plan and their fiduciary responsibilities in respect of Royalty Pharma's offer. The Elan Board should have retained all options to maximize shareholder value

    A copy of the Announcement is available at www.royaltypharma.com

    Definitions used in the Announcement have the same meaning when used in this announcement, unless the context requires otherwise.

    J.P. Morgan, together with its affiliate J.P. Morgan Cazenove, BofA Merrill Lynch, together with its affiliate Merrill Lynch International, and Groton Partners are acting as financial advisors to Royalty Pharma.

    Further information
    '/>"/>

    SOURCE Royalty Pharma
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Royalty Rates Take Center Stage in Biopharma Dealmaking
    2. Royalty Pharma Announces Proposal To Acquire Elan
    3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
    4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
    5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
    6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
    7. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
    9. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
    10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    11. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... 2014 Research and Markets  has announced ... 2014-2018" report to their offering. ... is a hollow needle commonly used with a syringe ... extract fluids from it. A hypodermic needle is used ... that cannot be ingested. Hypodermic needles are broadly classified ...
    (Date:7/11/2014)... -- On Thursday, July 10, 2014, ... Jones Industrial Average finished the day 0.42% lower at 16,915.07, ... losses were broad based as eight out of ten sectors ... Sector Index ended the day at 711.88, down 0.02%, while ... Investor-Edge has initiated coverage on the following equities: Covidien PLC ...
    (Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
    Breaking Medicine Technology:Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Veran Medical Publishes Lung Cancer Patient Management Study 2
    ... OAK BROOK, Ill. , July 12 The University ... agreement to Ascent, a leader in health care resource sustainability. The agreement, ... 1, 2010 . Under the contract, Ascent will offer single-use device (SUD) ... , , , ...
    ... July 12 ( http://www.myprgenie.com ) -- Medrium, Inc., one ... announced it has signed a partnership agreement with RelayHealth to use ... LabCorp and to provide LabCorp results to physicians utilizing the Medrium ... , ...
    Cached Medicine Technology:University HealthSystem Consortium Awards Single-Source Agreement to Ascent for Medical Device Reprocessing Services 2University HealthSystem Consortium Awards Single-Source Agreement to Ascent for Medical Device Reprocessing Services 3Medrium Partners With RelayHealth 2Medrium Partners With RelayHealth 3
    (Date:7/13/2014)... editorial published today in The Lancet Neurology ... consideration the long term neurological problems that repeated ... most common form of sports-related traumatic brain injury ... may include dementia, amyotrophic lateral sclerosis, and other ... is perhaps more concerning, is that even when ...
    (Date:7/13/2014)... identifies a novel genetic and molecular pathway ... opening up potential new therapeutic strategies for an ... is a chronic inflammatory disorder of the esophagus. ... certain foods and an over-accumulation in the esophagus ... the body,s immune system). EoE can cause a ...
    (Date:7/13/2014)... July 13, 2014 The North American water ... in 2013 to $5,450 million by 2018, at a CAGR ... market is expanding at a rapid pace in North America. ... tightening laws on water & wastewater storage and collection, and ... The market is expanding at a healthy rate in Canada, ...
    (Date:7/13/2014)... July 13, 2014 According to ... and Computing Market by Component (processor, GPU, DSP, ... MDA, Medical), and Geography - Forecast and Analysis ... Mobile Processing & Computing Market is expected to ... CAGR of 20.75% from 2014 to 2020. , ...
    (Date:7/13/2014)... WA (PRWEB) July 13, 2014 Athletes ... longer recovery period from concussions, according to research presented ... ( AOSSM ) Annual Meeting. The research marks the ... concussion based on the known physical events that occur ... patients with a long allele in the (GT)n genotype ...
    Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2
    ... Brain Center America,s New Neuroactive Exercise Bike Trains the Body and Brain ... ... Fitness centers are entering the next lap of their evolution with the ... body and the brain as a joint fitness program , Stephane Bergeron, ...
    ... Holdings Inc.,(OTC Bulletin Board: CLXS), a leading developer ... that their life science research,portal http://www.BiomedExperts.com ... in December has exploded to over 60,000 per ... , (Logo: ...
    ... Inc., the nation,s largest independent behavioral health care ... an agreement with CareIntegra to provide enhanced integrated ... product offerings. (Logo: http://www.newscom.com/cgi-bin/prnh/20090106/PH55551LOGO ... ValueOptions(R) will collaborate to develop and conduct a ...
    ... TV Teacher, LLC(TM) announces the,donation of their video-modeling programs ... Bronx, and Staten Island. , ... Ellis, a mother struggling to help her frustrated five-year-old ... an unsuccessful two years of,"traditional" therapy, she realized she ...
    ... Pharmaceutical,Inc. (Nasdaq: BMRN ) today announced that ... company update at the 27th,Annual J.P. Morgan Healthcare Conference ... a.m. PT. , Interested parties ... call,via the investor section of the BioMarin website, ...
    ... Jan. 7 Atlanta-based Billian Publishing, Inc.,owners of ... , (Logo: ... Porter Research was founded in 1989 just as ... of accelerated innovation. Since then, new,and established companies ...
    Cached Medicine News:Health News:Neuroactive Bike: America's First And Only Mind-Body Fitness Equipment Used For The Ultimate Brain Fitness Gym Program Launched This Month At Lady Of America Fitness Center 2Health News:Neuroactive Bike: America's First And Only Mind-Body Fitness Equipment Used For The Ultimate Brain Fitness Gym Program Launched This Month At Lady Of America Fitness Center 3Health News:Neuroactive Bike: America's First And Only Mind-Body Fitness Equipment Used For The Ultimate Brain Fitness Gym Program Launched This Month At Lady Of America Fitness Center 4Health News:Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year! 2Health News:Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year! 3Health News:ValueOptions(R) Enters Agreement with CareIntegra to Provide Integrated Health Services 2Health News:New York Schools Receive Program for Children with Autism 2Health News:BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Billian Publishing, Inc. Announces Acquisition of Porter Research 2
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    ... The Retinal Acuity Meter (RAM) is the ... to accurately predict RETINAL ACUITY in eyes with ... hand-held, battery operated, and can test each eye ... Optics, Inc. and tested at Columbia University in ...
    ... The Hoffmann® II Hybrid External Fixation ... next generation in hybrid fixation. It ... surgeons and is designed to offer ... exclusive patented Hoffmann® snap-fit technology. , ...
    ... add individual components for individual indications. XCaliber ... Made of an innovative composite plastic material, ... much lighter. This means it's easier to ... for the patient. ,Come pre-assembled, packaged sterile, ...
    Medicine Products: